|
|
|
|
| LEADER |
00000nam a22000001a 4500 |
| 001 |
b2064124 |
| 003 |
CStclU |
| 005 |
20141116084358.0 |
| 006 |
m d f |
| 007 |
cr bn mmmapmmp |
| 008 |
091024s1994 dcu sb f000 0 eng d |
| 035 |
|
|
|a cis2007474150
|
| 040 |
|
|
|a LexisNexis
|c LexisNexis
|d UtOrBLW
|
| 043 |
|
|
|a n-us---
|
| 074 |
|
|
|a 1031-A
|
| 074 |
|
|
|a 1031-B (MF)
|
| 086 |
0 |
|
|a Y 4.SM 1:103-80
|
| 088 |
|
|
|a Serial no. 103-80 (United States. Congress. House. Committee on Small Business)
|
| 110 |
1 |
|
|a United States.
|b Congress.
|b House.
|b Committee on Small Business.
|b Subcommittee on Regulation, Business Opportunities, and Technology.
|
| 245 |
1 |
0 |
|a RU-486, status report on the U.S. commercialization project, transfer of antiprogestin technology to the United States
|h [electronic resource] :
|b hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, second session, Washington, DC, May 16, 1994.
|
| 246 |
1 |
|
|a Congressional Hearings Digital Collection
|
| 264 |
|
1 |
|a Washington :
|b U.S. G.P.O.,
|c 1994.
|
| 264 |
|
2 |
|b For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office.
|
| 300 |
|
|
|a iii, 48 p. ;
|c 24 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a ProQuest Congressional
|
| 500 |
|
|
|a Record is based on bibliographic data in LexisNexis Congressional Hearings Digital Collection. Reuse except for individual research requires license from LexisNexis Academic & Library Solutions.
|
| 533 |
|
|
|a Electronic reproduction.
|b [Bethesda, Md.] :
|c LexisNexis Academic & Library Solutions,
|d 2004.
|e digital, PDF file.
|n LexisNexis U.S. Congressional Hearings Digital Collection.
|n Mode of access: World Wide Web via LexisNexis website.
|
| 538 |
|
|
|a System requirements: PDF reader software.
|
| 504 |
|
|
|a Includes bibliographical references (p. 46).
|
| 650 |
|
0 |
|a Mifepristone
|x Government policy
|z United States.
|
| 650 |
|
0 |
|a Progesterone
|x Antagonists
|x Government policy
|z United States.
|
| 650 |
|
0 |
|a Pharmaceutical policy
|z United States.
|
| 690 |
|
1 |
|a WWW.
|
| 740 |
0 |
|
|a LexisNexis U.S. Congressional Hearings Digital Collection.
|
| 740 |
0 |
|
|a ProQuest congressional publications.
|
| 776 |
0 |
8 |
|i Print version:
|a United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology.
|t RU-486, status report on the U.S. commercialization project, transfer of antiprogestin technology to the United States
|w gp 95054208
|w (OCoLC)31363910
|
| 776 |
0 |
8 |
|i Microfiche version:
|a United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology.
|t RU-486, status report on the U.S. commercialization project, transfer of antiprogestin technology to the United States.
|d [Bethesda, Md.] : LexisNexis Academic & Library Solutions,[2004]
|o CIS 94 H721-51
|w (LexisNexis)cis09401216
|
| 830 |
|
0 |
|a ProQuest Congressional.
|
| 856 |
4 |
0 |
|u https://congressional.proquest.com/congcomp/getdoc?HEARING-ID=HRG-1994-SMB-0006&accountid=13679
|z Connect to this title via ProQuest
|t 0
|
| 907 |
|
|
|a .b20641242
|b 240715
|c 100827
|
| 998 |
|
|
|a hwww
|b 100827
|c m
|d a
|e l
|f eng
|g dcu
|h 0
|
| 918 |
|
|
|a .bckstg
|b 2014-10-14
|
| 999 |
f |
f |
|i 7bb459bb-bba6-5be4-b323-cbb2c0c27bcf
|s d2ccb2a6-1a88-590f-8c72-4ca437c856c2
|t 0
|